Remedy Taking a hit why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Remedy Taking a hit why?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Barr who wrote (266)	9/13/1997 10:48:00 AM
From: Shege Dambanza	of 763

What you say about ARS is true; it can in fact be used in many different applications, and this allows a 'seed and proliferate' approach. On the other hand, my point is that each of these seeds will grow only so high, and a large enterprise will end up with a field of small saplings and not a small number of tall trees. While this may work as a strategy for RMDY, their architecture does not allow them to offer integrated enterprise-wide solutions. They continue to be typecast as a 'help-desk' vendor. Some of their partners (e.g. Baystone) are trying to develop enterprise applications using ARS as a platform, but have met with limited success to date. Obviously I'm not privy to RMDY's strategy, but it seems to me that they have to announce new markets and approaches if they are to continue to grow as they have in the past.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next